2023: Medtronic obtained CE mark approval for its Affera Mapping and Ablation System, designed for the treatment of atrial arrhythmias. According to MarkNtel Advisors study, The Global Minimally Invasive Surgery Market size is estimated to grow at a CAGR of around 17.8% during the forecast period, i.e., 2024-30. High initial investment costs pose a significant challenge to the growth of the Global Minimally Invasive Surgical Devices Market. The adoption & implementation of advanced technologies, such as robotic surgical systems like the Da Vinci Surgical System, sophisticated imaging equipment, and specialized instruments, require substantial upfront expenses. Robotic systems not only have high acquisition costs but…
Read More